Trials / Unknown
UnknownNCT00299351
A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (planned)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and tolerability of extended treatment with depsipeptide in patients who have at least demonstrated stable disease on prior Gloucester-sponsored depsipeptide clinical trials, and in the opinion of their physician/ investigator might benefit from continued treatment with depsipeptide
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Depsipeptide |
Timeline
- First posted
- 2006-03-06
- Last updated
- 2006-03-06
Source: ClinicalTrials.gov record NCT00299351. Inclusion in this directory is not an endorsement.